Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guided SSRI tapering with preventive cognitive therapy versus SSRI continuation during pregnancy
NL-OMON23074Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2015
- Countries
- 1
01
Overview
Randomised, open-label trial in major depressive disorder (MDD) (2 arms), sponsored by Erasmus MC. Primary endpoint: Cumulative incidence of maternal depressive relapse. Started Jan 2015; status: active, not recruiting.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON23074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23074.